港股開盤 | 三大指數再度暴漲,恆指重回21000點上方
香港恆生指數3月17日(週四)開盤上漲1343.21點,漲幅6.69%,報21430.71點;國企指數3月17日(週四)開盤上漲526.29點,漲幅7.64%,報7415.74點;紅籌指數3月17日(週四)開盤上漲159.13點,漲幅4.33%,報3836.67點。
隔夜中概股暴漲,大型科技股繼續暴力反彈,百度、京東、阿裏巴巴、美團均漲近15%,騰訊、快手漲超9%;汽車股、餐飲股、旅遊股、濠賭股、手機概念股、生物科技股、內房股與物管股再度攜手大漲,九毛九、小鵬汽車、碧桂園服務、龍湖集團均高開近15%。另一方面,惟內銀股少數走低,浙商銀行、交通銀行小幅下跌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.